ClinVar Miner

Submissions for variant NC_000022.11:g.(?_41154975)_(41164150_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000812010 SCV000952308 pathogenic Rubinstein-Taybi syndrome due to EP300 haploinsufficiency; Colorectal cancer 2018-11-08 criteria provided, single submitter clinical testing This variant is an out-of-frame deletion of the genomic region encompassing exons 17 to 22 of the EP300 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with EP300-related disease. Loss-of-function variants in EP300 are known to be pathogenic (PMID: 15706485, 24476420). For these reasons, this variant has been classified as Pathogenic.
Invitae RCV002245683 SCV001586930 pathogenic Rubinstein-Taybi syndrome due to EP300 haploinsufficiency; Colorectal carcinoma 2021-08-31 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.